Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients-Reference-Cited by-同舟云学术

Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients

Published:2022-09 Issue:6-7 Volume:24 Page:104976
ISSN:1286-4579
Container-title:Microbes and Infection
language:en
Short-container-title:Microbes and Infection

Author:

Anastasi Emanuela^ORCID,Marziali Marco,Preziosi Adele,Berardelli Elena,Losardo Anna Annunziata,Ribersani Michela,Pugliese Pellegrina,Farina Antonella^ORCID,Mancini Patrizia^ORCID,Angeloni Antonio

Funder

Sapienza Università di Roma

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Microbiology

Reference13 articles.

1. Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers;Salvagno;J Med Biochem,2021

2. Serum ferritin is an independent risk factor for acute respiratory distress syndrome in COVID-19;Gandini;J Infect,2020

3. Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering;Farina;Microb Infect,2021

4. Vitamin K deficiency and covid-19;Anastasi;Scand J Clin Lab Invest,2020

5. COVID-19 reinfection: linked Possibilities and future outlook;Krishna;J Fam Med Prim Care,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients;Transfusion Medicine;2024-04-17

2. Effects of Beta-Thalassemia on COVID-19 Outcomes;Thalassemia Syndromes - New Insights and Transfusion Modalities;2023-11-22

3. Clinical outcome and humoral immune responses of β-thalassemia major patients with severe iron overload to SARS-CoV-2 infection and vaccination: a prospective cohort study;eClinicalMedicine;2023-08

4. Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study;Hematology Reports;2023-07-12

5. Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2;Blood Reviews;2023-07